Adjuvant chemotherapy in soft tissue sarcomas…Conflicts, consensus, and controversies
Soft tissue sarcomas (STSs) are an uncommon and diverse group of more than 50 mesenchymal malignancies. Each of these histologic subtypes represents a unique disease with distinct biologic behavior and varying sensitivity to chemotherapy. The judicious use of adjuvant/neoadjuvant chemotherapy along...
Main Authors: | Jyoti Bajpai, Deepa Susan |
---|---|
Format: | Article |
Language: | English |
Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2016-01-01
|
Series: | South Asian Journal of Cancer |
Subjects: | |
Online Access: | http://journal.sajc.org/article.asp?issn=2278-330X;year=2016;volume=5;issue=1;spage=15;epage=19;aulast=Bajpai |
Similar Items
-
Feasibility of chemosensitivity testing in soft tissue sarcomas
by: Steinstraesser Lars, et al.
Published: (2005-04-01) -
Adjuvant therapy for orbital non-rhabdomyosarcoma soft tissue sarcoma: comparison of long-term outcome between radiotherapy and chemotherapy
by: Xiao-Feng Li, et al.
Published: (2023-03-01) -
Spine biomechanical testing methodologies: The controversy of consensus vs scientific evidence
by: John J. Costi, et al.
Published: (2021-03-01) -
Alveolar soft part sarcoma of orbit: A rare diagnosis
by: Pritee B. Chaudhari, et al.
Published: (2017-09-01) -
Integrative Clustering Reveals a Novel Subtype of Soft Tissue Sarcoma With Poor Prognosis
by: Zhenhua Zhu, et al.
Published: (2020-02-01)